-
1Academic Journal
Συγγραφείς: S. A. Lazarev, A. F. Lazarev, K. G. Mamontov, A. G. Kotelnikov, S. L. Khays, С. А. Лазарев, А. Ф. Лазарев, К. Г. Мамонтов, А. Г. Котельников, С. Л. Хайс
Πηγή: Surgery and Oncology; № 4 (2013); 42-49 ; Хирургия и онкология; № 4 (2013); 42-49 ; 2949-5857 ; 10.17650/2220-3478-2013-0-4
Θεματικοί όροι: preoperative regional chemotherapy, prognosis factors, периоперационная регионарная химиотерапия, факторы прогноза
Περιγραφή αρχείου: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/97/91; Давыдов М.И. Аксель Е. Заболеваемость злокачественными новообразованиями населения России и стран СНГ в 2008 году. Вестник РОНЦ им. Н.Н. Блохина 2010;21(прил. 1):59.; Lawes D., Taylor I. Chemotherapy for colorectal cancer – an overview of current management for surgeons. Eur J Surg Oncol 2005;31(9):932–41.; Kemeny M.M., Adak S., Gray B. et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy – an intergroup study. J Clin Oncol 2002;20(6):1499–505.; Adam R., Laurent A., Azoulay D. et al. Two stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777–85.; Azoulay D., Eshkenazy R., Andreani P. et al. In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection. Ann Surg 2005;241:277–85.; Azoulay D., Andreani P., Maggi U. et al. Combined liver resection and reconstruction of the supra-renal vena cava: The Paul Brousse experience. Ann Surg 2006;244: 80–8.; Hemming A.W., Reed Al., Langham M.R. Jr et al. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 2004;239:712–9.; Abdalla E.K., Adam R., Bilchik A.J. et el. Improving respectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13(10):1271–80.; Clavien P.A., Petrowsky H., DeOliveira M.L., Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356(15):1545–59.; Патютко Ю.И. Хирургическое лечение злокачественных опухолей печени. М., 2005. 320 с.; Nordlinger B., Van Cutsem E., Gruenberger T. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009;20(6):985–92.; Nordlinger B., Sorbye H., Glimelius B. et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectacancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371(9617):1007–16.; Гранов Д.А., Таразов П.Г. Рентгенваскулярные вмешательства в лечении злокачественных опухолей печени. СПб.: Фолиант, 2002. 288 с.; Neumann U.P., Seehofer D., Neuhaus PThe surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010 May;107(19):335–42.; Adam R., Pascal G., Castaing D. et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240(6):1052–60.; Weber S.M., Jarnagin W.R., DeMatteo R.P. et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7(9):643–50.; Adam R., Delvart V., Pascal G. et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-termsurvival. Ann Surg 2004;240:644–57.; Журавлев В.А. Радикальные операции у «неоперабельных» больных с очаговыми поражениями печени. Киров: ГИПП «Вятка», 2000.; Wicherts D.A., Miller R., de Haas R.J.et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008;248:626–37.; Adam R., Wicherts D.A., de Haas R.J. et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009;27:1829–35.; Bismuth H., Adam R., Levi F. et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–20.; Kemeny N.E. Current approaches for liver-only metastases in colorectal cancer. Com Oncol 2006;3(6):26–35.; Elias D., Liberale G., Vernerey D. et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005;11:900–9.; D’Angelica M., Kornprat P., Gonen M. et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007;14:759–65.; Mahfud M., Breitenstein S., El-Badry A.M. et al. Impact of preoperative bevacizumab on complications after resectionof colorectal liver metastases: case-matched control study. World J Surg 2010;34(1):92–100.; Reddy S.K., Morse M.A., Hurwitz H.I. et al. Addition of bevacizumab to irinotecan and oxaliplatin-based preoperative regimens does not increase morbidity after resection of colorectal liver metastases. J Am Coll Surg 2008;206:96–106.; Zacharias T., Jaeck D., Oussoultzoglou E. et al. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 2004;240:858–65.; Petrowsky H., Gohen M., Jarnagin W. et al. Second liver resection are safe and effective treatment for recurrent hepatic metastases from colorectal cancer(a bi-institutional analysis). Ann Surg 2002;235(6):863–71.; Elias D., Ouellet J.F., Bellon N. et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal metastases. Br J Surg 2003;90(5):567–74.; Elias D., Sideris L., Pocard M. et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004;11(3):274–80.; Poston G.J., Adam R., Alberts S. et al. OncoSurge: A strategy for improving respectability with curative intent in metastatic colorectal cancer. J Clin Oncol 2005;23:7125–34.
-
2Academic Journal
Πηγή: Онкологическая колопроктология.
Θεματικοί όροι: МЕТАСТАЗЫ КОЛОРЕКТАЛЬНОГО РАКА В ПЕЧЕНЬ, ПЕРИОПЕРАЦИОННАЯ РЕГИОНАРНАЯ ХИМИОТЕРАПИЯ, ФАКТОРЫ ПРОГНОЗА, 3. Good health
Περιγραφή αρχείου: text/html
-
3Academic Journal
Πηγή: Анналы хирургии.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, МЕТАСТАЗЫ КОЛОРЕКТАЛЬНОГО РАКА В ПЕЧЕНИ, ПЕРИОПЕРАЦИОННАЯ РЕГИОНАРНАЯ ХИМИОТЕРАПИЯ, КРОВОПОТЕРЯ, ПОСЛЕОПЕРАЦИОННЫЕ ОСЛОЖНЕНИЯ, 3. Good health
Περιγραφή αρχείου: text/html
